Title View
Consolidated Financial Statements as of September 30, 2025
Consolidated Financial Statements as of June 30, 2025
Consolidated Financial Statements as of March 31, 2025
Consolidated Financial Statements as of September 30, 2024
Consolidated Financial Statements as of June 30, 2024
Consolidated Financial Statements as of March 31, 2024
Consolidated Financial Statements as of September 30, 2023
Consolidated Financial Statements as of June 30, 2023
Consolidated Financial Statements as of March 31, 2023
Shape
Potential life-changing treatments are on the way

Each molecule in our development pipeline is carefully selected for its potential ability to improve upon the standard of care, delivering maximum value to patients

Discover our Pipeline